secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0000950170-21-004812
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences Chief Growth Officer Chris Cuvelier to Depart Nov 30, 2021
------------------------------------------------------------------------------

- Chris Cuvelier's employment as Chief Growth Officer will end effective November 30, 2021.
- The decision was reached on November 15, 2021, as reported by Arcadia Biosciences.
- The company filed an 8-K with the SEC on November 19, 2021, disclosing the officer departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017021004812/0000950170-21-004812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017021004812/rkda-20211115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-004812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer